Third, the causality between VPS35 inhibition and copper metabolism disorders was partially demonstrated in the present study, however VPS35 was not knocked out in vivo to further confirm the relationship between VPS35 and copper overload, as well as the upstream regulatory mechanism in brain-heart comorbidities. The gene discussed is VPS35; the disease is disorder of copper metabolism.